Vanguard Personalized Indexing Management, LLC Rocket Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,418 shares of RCKT stock, worth $38,546. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,418
Previous 12,351
15.65%
Holding current value
$38,546
Previous $30,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RCKT
# of Institutions
219Shares Held
98.4MCall Options Held
608KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$65.4 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$30.9 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$22.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$22.7 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$17.8 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $280M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...